Published in Gene Therapy Weekly, August 17th, 2006
"Subacute sclerosing panencephalitis (SSPE) is a rare, but fatal outcome of MeV infection. SSPE develops after prolonged persistence of mutated MeV called SSPE virus.
"Although a combination therapy using interferon and inosiplex or ribavirin appears to prolong survival time to some extent, there is currently no effective treatment to completely cure SSPE and a new treatment strategy is greatly needed," wrote M. Otaki and colleagues, Kobe University.
"In this study, we adopted RNAi...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.